Mônica R. Gadelha

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

Mônica R. Gadelha, Marcello D. Bronstein, Thierry Brue et al. · The Lancet Diabetes & Endocrinology · 2014 · 402 citations

Medicine, Endocrinology, Pharmacotherapy +4

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

Annamaria Colao, Marcello D. Bronstein, Pamela U. Freda et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 394 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update

Andrea Giustina, Ariel Barkan, Albert Beckers et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 364 citations · Full text

Medicine, Clinical Sciences, Endocrinology +9

The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

Chrysanthia A. Leontiou, Maria Gueorguiev, Jacqueline van der Spuy et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 294 citations · Full text

Medicine, Endocrinology, Molecular Genetics +17

Quantitative analysis of somatostatin receptor subtype (SSTR1–5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

Giselle Fernandes Taboada, Raúl M. Luque, Wildebranham Bastos et al. · European Journal of Endocrinology · 2007 · 222 citations

Medicine, Endocrinology, Oncology +17